Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Man Killed in Crash on Glenoaks Boulevard


Car Splits in 2 in Fatal Solo-Vehicle Accident in Los Angeles

Fatal Accident 7

Los Angeles, CA (October 4, 2019) – A man was killed in a solo-vehicle crash in Los Angeles. The fatal accident occurred on the morning of October 4 on Glenoaks Boulevard.

The vehicle was heading north on Glenoaks Boulevard, near Van Nuys Boulevard, at a high-rate of speed. The male driver lost control and hit a power pole. The force of the crash was so great that the car split in two. The driver died at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Los Angeles

#91331


October 7, 2019

Guddi Sidhu Killed in Crash at Ashlan and Cornelia Avenues

Vehicle Thrown Into Air in Fatal Fresno Accident Fresno, CA (October 6, 2019) ...


November 5, 2019

1 Killed, 4 Injured in Crash on Highway 198 Near Pine Valley Road

Pickup Truck Catches Fire, Overturns in Fatal King City Accident...


May 29, 2020

1 Injured in Crash on Business 80 Near Exposition Boulevard

2 Vehicles Collide in Sacramento Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.